Bio / HealthcareStock
MRK: Merck Nears 52-Week High, But Overbought RSI Signals a Wait-and-See Approach Before Chasing Upside to $128.04 [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep…
March 30, 2026
Bio / HealthcareStock
BMY: Bristol-Myers Squibb Dips, But Strong Technicals Signal a Potential Rebound. [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive Bristol-Myers Squibb Company (BMY) $58.54…
March 29, 2026
Bio / HealthcareStock
Pfizer (PFE): Nearing 52-Week High, But Technicals Signal Caution — [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive Pfizer Inc. (PFE) $27.04 Veqtio ·…
March 28, 2026
Bio / HealthcareStock
LLY: Eli Lilly Plunges 22% From Highs – Is This a High-Conviction Dip or a Falling Knife? [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep…
March 28, 2026
Bio / HealthcareStock
TMO Stock: Down 26% from 52-Week High, But Analysts See 40% Upside. Is This a Falling Knife or a High-Conviction Dip? [Verdict: WAIT] 🇺🇸 Veqtio…
March 28, 2026
Bio / HealthcareStock
CVS Health: Deeply Oversold, But Is This Falling Knife Ready for a Catch? [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive CVS Health Corporation…
March 27, 2026
Bio / HealthcareStock
Centene (CNC) Plunges to Analyst Lows: Is a 34% Upside Worth the Falling Knife Risk? [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive Centene…
March 27, 2026
Bio / HealthcareStock
Cencora (COR) Plunges to Extreme Oversold Levels: Is This a High-Conviction Dip or a Falling Knife? [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive…
March 27, 2026
Bio / HealthcareStock
ABBV: Wait for the Dip? $211.70 Price, +17.7% Upside, Strong Technicals but Lacking Immediate Catalyst [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive AbbVie…
March 27, 2026
Bio / HealthcareStock
ABT: Plunging to 52-Week Lows with 27% Upside? Why You Should WAIT for a Clearer Signal [Verdict: WAIT] 🇺🇸 Veqtio · US Equity Deep Dive…
March 27, 2026
Bio / HealthcareStock
[IBRX] ImmunityBio: Oversold Biotech Poised for a +77% Upside? [Verdict: BUY] 🇺🇸 Veqtio · US Equity Deep Dive [IBRX] ImmunityBio, Inc. $8.47 Veqtio · AI-Powered…
March 22, 2026
Bio / HealthcareStock
[RGC] Regencell Bioscience: Biotech’s Volatile Ride, Is a Pullback Coming? [Verdict: WAIT] [RGC] Regencell Bioscience Holdings L $27.37 Veqtio · AI-Powered Equity Research · veqtio.com…
March 21, 2026